Table 2.

Infusion rates and daily levodopa equivalents during 16-h and after transition to 24-h LCIG infusion

Patient	Daytime CR on 16-h therapy	Total daily L-DOPA equivalent on 16-h infusion (or oral therapy if direct to 24h Rx)	Daytime CR on 24-h infusion at time of follow-up assessment	Night CR on 24-h infusion at time of follow-up assessment	Total daily L-DOPA equivalent on 24-h infusion (after initial titration)	Change in 24 h levodopa dose (%)	Most recent day rate	Most recent night rate	Most recent follow up 24-h L-DOPA equivalent	Change in 24 h L-DOPA dose since 24-h therapy initiation and latest follow-up (%)	Follow-up duration ON 24-h LCIG (months)
1	4.1	1572	3.9	3	1734	110	5.1	4.1	2260	130%	57
2	1.5	570	1.5	1.1	656	115	2.2	1.5	944	127%	54
3	3.8	1394	3.9	1.7	1550	111	4.5	4.3	2158	139%	49
4	6.7	2364	2	2	960	41	4.5	3.2	2080	217%	43
5	6.1	2292	6.1	4.2	2744	120	4.5	2.6	1856	68%	33
6	7	2550	7.3	5.1	3292	129	8	6	3664	115%	28
7	3	1270	4.3	3	1936	152	5.4	3.5	2368	172%	27
8	5.1	2102	3.5	3.5	1300	62	4.1	2.7	1764	135%	25
9	n/a	1380	5.4	3.2	1604	116	5.5	3.2	2452	152%	23
10	n/a	1275	5.7	4.7	2656	208	6.1	4.9	2796	135%	20
11	2.6	966	3	2.1	1390	144	3.5	2.5	1562	136%	15
12 (treatment 1)	n/a	1125	5.1	3.5	2192	195	2.2	0.5	716	33%	48
12 (treatment 2)	2.8	784	2.8	0.5	1016	130	2.2	0.5	716	91%	12